Robert Greif is the Pres at H-CYTE.
As the Pres of H-CYTE, the total compensation of Mr Greif at H-CYTE is $484,829. There are 1 executives at H-CYTE getting paid more, with William Horne having the highest compensation of $2,372,870.
Mr Greif is 56, he's been the Pres of H-CYTE since . There are 2 older and 6 younger executives at H-CYTE. The oldest executive at H-CYTE, Inc. is Raymond Monteleone, 72, who is the Director.
Robert's mailing address filed with the SEC is 201 E KENNEDY BLVD, SUITE 700, , TAMPA,, FL, 33606.
Over the last 6 years, insiders at H-CYTE have traded over $0 worth of H-CYTE stock and bought 60,000 units worth $8,050 . The most active insiders traders include Todd Rfwhc Holdings, Llc Wa..., J Rex Iiifwhc Holdings, Llc... oraz Michael Yurkowsky. On average, H-CYTE executives and independent directors trade stock every 286 days with the average trade being worth of $10,590,590. The most recent stock trade was executed by J Rex Iiifwhc Holdings, Llc... on 23 February 2022, trading 693,477 units of HCYT stock currently worth $6,935.
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute biologics for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.
H-CYTE executives and other stock owners filed with the SEC include: